Pepptin Biologistics Laboratories · British Columbia, Canada

Peptides are the story of the decade.
We make the part you can actually buy.

Eight outcome-specific wellness systems — oral formulas and topical companions, co-designed around peptide science, GMP-manufactured, and lawful in Canada and the United States by construction. No grey market. No fine-print fictions.

Join the launch waitlist Read the Peptide Report
LAUNCHING JUNE 2027 · SUBSCRIPTIONS FROM $85/MO · CANADA + US
One system · three layers · two routes
SIGNAL the peptide that instructs the tissue SUBSTRATE the amino acids it builds with COFACTORS the minerals the steps require
Oral system
+ Topical companion where the outcome is skin-deep

Legality is our design language. Every peptide we discuss — on this site, in our papers, in our feed — is published with its current regulatory status in Canada and the US. If a compound isn't lawful, we say so, and we don't sell it.

SELLING NOW Rx ONLY UNDER REVIEW NOT LAWFUL
The Phase 1 Formulary

Eight systems. Eight named outcomes.

Not ingredients — systems. Each subscription pairs an oral formula (and, where the tissue can be reached from the surface, a topical companion) around one outcome, at ratios our formulation team will defend line by line.

SYSTEM 01 · ORAL + TOPICAL

Inside Out Collagen

Skin elasticity and visible aging — addressed from the bloodstream and the surface at once.
$165/moJUN 2027
SYSTEM 14 · ORAL

Joint Health & Cartilage

Joint comfort and mobility for active adults, built on the best-studied collagen classes.
$85/moJUN 2027
SYSTEM 18 · ORAL

Bone Density

Structural support for the years that test it — the outcome with the strongest evidence most brands ignore.
$90/moJUN 2027
SYSTEM 24 · ORAL

Sports Performance & Recovery

Training recovery without the grey-market gamble — whey and creatine peptide science, done properly.
$132.50/moJUN 2027
SYSTEM 21 · ORAL

Cardiovascular Health

Food-derived bioactive peptides supporting cardiovascular wellness.
$87.50/moQ3 2027
SYSTEM 15 · ORAL + TOPICAL

Women's Hormonal Balance

Comfort and wellness through the transition years, inside and out.
$142.50/moQ4 2027
SYSTEM 10 · ORAL + TOPICAL

Skin Brightening

Even tone and brightness — an oral antioxidant matrix with a peptide topical companion.
$165/moQ1 2028
SYSTEM 12 · ORAL + TOPICAL

Hair Restoration

Thickness and strength supported from the follicle's two sides: nutrition and scalp.
$145/moQ2 2028
The Formulation Thesis

Single actives are rate-limited.
Systems are not.

Collagen synthesis — like every process our systems target — is multi-step. Supply one step and the result is limited by whichever step you skipped. Our formulas supply all three, at defined ratios. The ratios are what we patent.

LAYER 1

The Signal

A peptide or peptide-adjacent active that instructs the target tissue — collagen fragments that tell fibroblasts to build, topical signal peptides at the concentrations the studies actually used.

LAYER 2

The Substrate

The free-form amino acids the tissue needs to act on that instruction. A signal without material is a work order sent to an empty warehouse.

LAYER 3

The Cofactors

The vitamins and minerals the enzymatic steps require. Small quantities, non-negotiable chemistry.

Why Lawful Matters

The grey market discovered the demand.
It cannot be trusted with it.

A $100M+/year economy sells "research chemicals" to human users with no approval, no quality control, and no accountability. We exist to serve that demand the other way — with everything the grey market cannot offer.

The grey market

  • Unlawful for human use — "research purposes" is a label, not a protection
  • No GMP, no batch testing, no recall capability
  • No adverse-event system, no accountability
  • Independent testing found 37 of 37 samples of one popular compound failed purity
37/37 FAILED — independent purity testing of grey-market retatrutide samples, 2026

Pepptin

  • Every product lawful in Canada and the US before it ships — by construction
  • Manufactured in a multi-licensed GMP facility that also produces for major pharmacy retail
  • Every batch tested and documented; we hold final release authority
  • Every compound we discuss published with its real legal status — including the ones we refuse to sell
The Knowledge Hub

White papers. Free. Public domain.

The peptide category is drowning in hype and starving for straight answers. We publish ours openly — take them, cite them, share them. Authority is our marketing budget.

Start here · 9:54

What a peptide actually is

Amino acids, sequence, and why a peptide behaves more like a message than a material. Then the question that decides everything: can it reach the right cells, in a form they recognise, in a sufficient amount?

We grade the evidence family by family — strong, moderate, early, or primarily preclinical — and use GHK-Cu as the worked example. A result in a dish is not a result in a person.

Go deeper: GHK-Cu, Honestly → Go deeper: Reading the Evidence → Go deeper: The Four Worlds →

Educational material. Not medical advice, and not a recommendation of any substance or product. The video loads only when you press play — or watch it on YouTube.

WP-001FREE · PUBLIC DOMAIN

The Four Worlds of Peptide Regulation

Drug, cosmetic, natural health product, supplement — how one molecule can live four legal lives, and how to read the difference.

Download PDF →
WP-002FREE · PUBLIC DOMAIN

The 12 Peptides Under Review

The verified timeline of the 2026 reclassification — what the PCAC actually voted, what remains undecided, and what it means for consumers.

Download PDF →
WP-003FREE · PUBLIC DOMAIN

Collagen Peptides: Reading the Evidence

What randomised trials actually show for skin, joints, and bone density — and what dose and duration they showed it at.

Download PDF →
WP-004FREE · PUBLIC DOMAIN

GHK-Cu, Honestly

Fifty years of copper-peptide science, what's lawful (topical) versus what isn't (injectable), and how to read a label.

Download PDF →
WP-005FREE · PUBLIC DOMAIN

The Grey-Market Formulary

What people are actually buying, what they're taking it for, and what the purity data says. Market intelligence, published.

Download PDF →
WP-006FREE · PUBLIC DOMAIN

Why Peptide Manufacturing Is the Real Bottleneck

The $4.2B capacity race, the licence stack, and why building a compliant facility takes years, not quarters.

Download PDF →

Public domain means public domain. Our white papers are released without copyright restriction. Journalists, clinicians, educators, competitors: use them. Every accurate sentence in circulation about peptide legality makes our market bigger and the grey market smaller.

The Peptide Report

The industry feed. Constantly updated,
always sourced, status-stamped.

Regulatory moves, published science, and industry signals — logged as they happen, each entry tagged and dated. This is the feed we run our own regulatory watch on. Now it's yours too.

Loading the feed…
Sell With Us

A partner network built to survive scrutiny.

Our sales structure separates capital from selling — permanently. Nobody buys the right to earn. Nobody earns for recruiting. Commission is paid on verified customer sales, full stop.

TRACK A · EQUITY

Founders

25 territory seats. A preferred-share investment — permanent, never performance-contingent, never clawed back.

Fully separate from selling. Founders anchor territories; their shares don't depend on anyone's sales, and no sale depends on their shares.

Subject to counsel clearance — agreements are signed only after securities and consumer-protection review completes. That's a feature.

TRACK B · COMMISSION

The Sales Force

Costs nothing to join. No kit, no inventory requirement, no fee — ever.

Paid on real sales only. Agents 15% · Sub-Distributors 5% · Distributors 10% — on verified customer subscriptions and every renewal, never on recruiting.

Trained and certified. Every partner passes product and claims certification before their first sale. One approved claims library, no freelancing.

Register partner interest

Launching June 2027.
The waitlist is open now.

Be first for the Phase 1 systems, the white papers as they publish, and the Peptide Report. Tell us what you're here for and we'll keep it relevant.